A Descriptive Study on the Proper Management of Gastrointestinal Surgeries During the COVID-19 Pandemic, With an Emphasis on the Alteration of Surgical Protocol and Workflow
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Gastric Cancer
- Sponsor
- Beijing Friendship Hospital
- Enrollment
- 500
- Primary Endpoint
- treatment of post-operative fevers
- Last Updated
- 5 years ago
Overview
Brief Summary
This is a multi-centered, retrospective, observational study aimed at observing the current status of the management of gastrointestinal surgery during the COVID-19 pandemic, particularly the changes on surgery protocols and other key aspects of surgical workflow, so as to share experience with colleagues both domestic and abroad.
Investigators
Zhongtao Zhang
Professor
Beijing Friendship Hospital
Eligibility Criteria
Inclusion Criteria
- •All patients arriving at surgical emergency and all patients receiving gastrointestinal surgeries in participating centers from 2020.1.1\~2020.3.31.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
treatment of post-operative fevers
Time Frame: 1 day
proportion of patients on whom fever occured, proportion of patients screened for COVID-19, method of screening (CT? nucleated acid test?)
treatment of fevers at arrival
Time Frame: 1 day
proportion of patients presented with fever, proportion of patients refered to fever clinics, proportion of patients screened for COVID-19, method of screening (CT? nucleated acid test?)
assorted surgical parameters
Time Frame: 1 day
Duration of operation (≥180min/\<180min); Intra-operative transfusion (Y/N); Surgical approach (Laparoscopy-involved/Open); Resection range (Non-radical/Radical); Lymph node dissection (Unknown/Not dissected/D1/D2 or above); Combined organ resection (Y/N); Post-operative complications (Y/N); Post-operative transfusion (Y/N); Post-operative hospital stay (≥7d/\<7d)
Secondary Outcomes
- hospitals' protection measures and extent of implementation(1 month)